A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

Clinical trial NCT04668339 · TERMINATED

Trial details

NCT number: NCT04668339
Sponsor: Arcturus Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 SARS-CoV Infection Corona Virus Infection

Start date: 2021-01-07
Primary completion: 2022-03-01
Enrollment: 581

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.